24,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
12 °P sammeln
  • Broschiertes Buch

The nano formulation is expected to deliver the next generation bone cement with tailor-designed antibiotics release profiles and prolonged antibacterial activity. The key commercial advantages to potential bone cement manufacturers and end users are sustained antibiotics release, reduction in standard antibiotics dosage, minimised use of intravenous doses and creating new opportunities to use other benefit ingredient for local targeted delivery. Once commercialized, the socio-economic impact and savings in medical resources and costs are expected to be significant as the risk of post-operative infections can be reduced.…mehr

Produktbeschreibung
The nano formulation is expected to deliver the next generation bone cement with tailor-designed antibiotics release profiles and prolonged antibacterial activity. The key commercial advantages to potential bone cement manufacturers and end users are sustained antibiotics release, reduction in standard antibiotics dosage, minimised use of intravenous doses and creating new opportunities to use other benefit ingredient for local targeted delivery. Once commercialized, the socio-economic impact and savings in medical resources and costs are expected to be significant as the risk of post-operative infections can be reduced.
Autorenporträt
El Dr. Shen se doctoró en 2001 y se incorporó al Instituto de Ciencias Químicas e Ingeniería en 2005. Se centró en la formulación de fármacos con materiales nanoestructurados. Hasta la fecha, ha publicado más de 60 artículos en revistas académicas y 5 capítulos de libros. Se le han concedido 2 patentes en EE.UU. y 2 en Singapur, y ha solicitado 1 patente PCT.